Innovative strategies for the treatment of CLL

Leukemia and Lymphoma

Volumn 22, Issue SUPPL. 2, 1996, Pages 53-64

  Keating, M ^a   Cheson, B ^b   Gribben, J G ^c   Robertson, B ^d   Nadler, L ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d Savannah Hematology Oncology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYSTAUROSPORINE; 9 AMINOCAMPTOTHECIN; BETA 2 MICROGLOBULIN; BRYOSTATIN; CYTOTOXIC AGENT; DOCETAXEL; FENRETINIDE; FLUDARABINE PHOSPHATE; IRINOTECAN; LOXORIBINE; PACLITAXEL; PENTOSTATIN; PURINE DERIVATIVE; RETINOID; TAXANE DERIVATIVE; TOPOTECAN; VINCRISTINE;

BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CANCER IMMUNOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; DIARRHEA; HUMAN; INFLAMMATION; LEUKOPENIA; MYALGIA; NEUTROPENIA; NIGHT BLINDNESS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030460580     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609102703     Document Type: Conference Paper

References (15)

1. Robertson, L. E. and Keating, M. J. (1991) Therapeutic approaches to chronic lymphocytic leukaemia. Tex. Med., 87, 68-74.
2. Keating, M. J., Estey, E., O'Brien, S., Kantarjian, H., Robertson, L. E. and Plunkett, W. (1994) Clinical experience with fludarabine in leukaemia. Drugs, 47 (Suppl. 6), 39-49.
3. Keating, M. J., O'Brien, S., Robertson, L., Huh, Y., Kantarjian, H. and Plunkett, W. (1993) Chronic lymphocytic leukaemia - correlation of response and survival. Leuk. Lymphoma, 11 (Suppl. 2), 167-175.
4. Robertson, L. E., Huh, Y. O., Butler, J. J., Pugh, W. C., Hirsch-Ginsberg, C., Stass, S., Kantarjian, H. and Keating, M. J. (1992) Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic and molecular analysis. Blood, 80, 29-36.
5. 2-microglobulin level is more powerful than stage in predicting response and survival in chronic lymphocytic leukaemia (CLL). Proceedings of the thirty-seventh meeting of the American Society of Hematology, December.
6. Furue, H. (1993) Topoisomerase inhibitors developing in Japan. Gan To Kagaku Ryoho, 20, 42-49.
7. Silber, R., Degar, B., Costin, D., Newcomb, E. W., Mani, M., Rosenberg, C. R., Morse, L., Drygas, J. C., Canellakis, Z. N. and Potmesil, M. (1994) Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine and camptothecin analogs. Blood, 84, 3440-3446.
8. O'Brien, S., Kantarjian, H., Ellis, A., Zwelling, L., Estey, E. and Keating, M. (1995) Topotecan in chronic lymphocytic leukemia. Cancer, 75, 1104-1108.
9. Bollag, W. and Holdener, E. E. (1992) Retinoids in cancer prevention and therapy. Ann. Oncol., 3, 513-526.
10. Goodman, M. G., Wormsley, S. B., Spinosa, J. C. and Piro, L. D. (1994) Loxoribine induces chronic lymphocytic leukemic B cells to traverse the cell cycle. Blood, 84, 3457-3464.
11. al-Katib, A., Mohammad, R. M., Dan, M., Hussein, M. E., Akhtar, A., Pettit, G. R. and Sensenbrenner, L. L. (1993) Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro. Exp. Hematol., 21, 61-65.
12. Khouri, I. F., Keating, M. J., Vriesendorp, H. M., Reading, C. L., Przepiorka, D., Huh, Y. O., Andersson, B. S., van Besien, K. W., Mehra, R. C. and Giralt, S. A. (1994) Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukaemia: preliminary results. J. Clin. Oncol., 12, 748-758.
13. Rabinowe, S. N., Soiffer, R. J., Gribben, J. G., Daley, H., Freedman, A. S., Daley, J., Pesek, K., Neuberg, D., Pinkus, G. and Leavitt, P. R. (1993) Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B cell chronic lymphocytic leukemia. Blood, 82, 1366-1376.
14. Vuillier, F., Claisse, J. F., Vandenvelde, C., Travade, P., Magnac, C., Chevret, S., Desablens, B., Binet, J. L. and Dighiero, G. (1992) Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone marrow remission using CD5-CD19 markers and PCR study of gene rearrangements. Leuk. Lymphoma, 7, 195-204.
15. Rugiatelli, B. et al. (1989) Cancer, 63, 1979-1984.